Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation

Obesity

Volumn 18, Issue 7, 2010, Pages 1283-1288

  Sargis, Robert M ^a   Johnson, Daniel N ^a   Choudhury, Rashikh A ^a   Brady, Matthew J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDRIN; ESTROGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LUCIFERASE; PHENOL DERIVATIVE; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DICYCLOHEXYL ESTER; PLASMA PROTEIN; PREDNISONE; BENZHYDRYL DERIVATIVE; DICYCLOHEXYL PHTHALATE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN 3T3; DRUG EFFECT; ENDOCRINE SYSTEM; ENVIRONMENT; GENETIC SCREENING; GENETICS; LIPID METABOLISM; METABOLISM; MOUSE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPORTER GENE; STEM CELL; 3T3 CELL LINE; DRUG EFFECTS;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BLOOD PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; ENDOCRINE SYSTEM; ENDRIN; ENVIRONMENT; ESTROGENS, NON-STEROIDAL; GENES, REPORTER; GENETIC TESTING; GLUCOCORTICOIDS; LIPID METABOLISM; LUCIFERASES; MICE; OBESITY; PHENOLS; PHTHALIC ACIDS; PREDNISONE; RECEPTORS, GLUCOCORTICOID; STEM CELLS; BENZHYDRYL COMPOUNDS;

EID: 77954104861     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.419     Document Type: Article

References (40)

1. Qi L, Cho YA. Gene-environment interaction and obesity. Nutr Rev 2008;66: 684-694.
2. Bessesen DH. Update on obesity. J Clin Endocrinol Metab 2008;93: 2027-2034.
3. Baillie-Hamilton P F. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002;8:185-192.
4. Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006;147:S50-S55.
5. Hatch EE, Nelson JW, Qureshi MM et al. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 2008;7:27.
6. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR Jr. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2007;30:622-628. (Pubitemid 46354344)
7. Lee DH, Lee IK, Song K et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006;29:1638-1644.
8. Hodges LC, Bergerson JS, Hunter DS, Walker CL. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro. Toxicol Sci 2000;54:355-364.
9. Hofmann PJ, Schomburg L, Köhrle J. Interference of endocrine disrupters with thyroid hormone receptor-dependent transactivation. Toxicol Sci 2009;110:125-137.
10. Gregoire FM. Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) 2001;226:997-1002.
11. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809.
12. Grün F, Watanabe H, Zamanian Z et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 2006;20:2141-2155.
13. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway. Mol Pharmacol 2005;67:766-774.
14. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005;84:319-327.
15. Masuno H, Kidani T, Sekiya K et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 2002;43:676-684.
16. Feige JN, Gelman L, Rossi D et al. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 2007;282:19152-19166.
17. Hurst CH, Waxman DJ. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 2003;74:297-308.
18. Venkata NG, Robinson JA, Cabot PJ et al. Mono(2-ethylhexyl) phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast. Toxicol Lett 2006;163:224-234.
19. Gumy C, Chandsawangbhuwana C, Dzyakanchuk AA et al. Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production. PLoS ONE 2008;3:e3545.
20. Johansson M, Nilsson S, Lund BO. Interactions between methylsulfonyl PCBs and the glucocorticoid receptor. Environ Health Perspect 1998;106:769-772.
21. Johansson M, Johansson N, Lund BO. Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells. Basic Clin Pharmacol Toxicol 2005;96:309-315.
22. Atanasov AG, Nashev LG, Tam S, Baker ME, Odermatt A. Organotins disrupt the 11beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids. Environ Health Perspect 2005;113: 1600-1606.
23. Atanasov AG, Tam S, Röcken JM, Baker ME, Odermatt A. Inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates. Biochem Biophys Res Commun 2003;308:257-262.
24. Odermatt A, Gumy C, Atanasov AG, Dzyakanchuk AA. Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance. J Steroid Biochem Mol Biol 2006;102:222-231.
25. Cowherd RM, Lyle RE, McGehee RE Jr. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 1999;10:3-10.
26. Brady MJ, Kartha PM, Aysola AA, Saltiel AR. The role of glucose metabolites in the activation and translocation of glycogen synthase by insulin in 3T3-L1 adipocytes. J Biol Chem 1999;274:27497-27504.
27. Temple KA, Cohen RN, Wondisford SR et al. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. J Biol Chem 2005;280:3529-3540.
28. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999;140:3188-3196.
29. Kim J, Temple KA, Jones SA et al. Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels. J Biol Chem 2007;282:11038-11046.
30. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002;290:1084-1089.
31. Baugh JE Jr, Floyd ZE, Stephens JM. The modulation of STAT5A/GR complexes during fat cell differentiation and in mature adipocytes. Obesity (Silver Spring) 2007;15:583-590.
32. Botella B, Crespo J, Rivas A et al. Exposure of women to organochlorine pesticides in Southern Spain. Environ Res 2004;96:34-40.
33. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008;116:39-44.
34. Lee YJ, Ryu H Y, Kim HK et al. Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol 2008;25:413-419.
35. Colborn TD, D., Meyers, J.P. Our Stolen Future. Plume: New York, 1996.
36. Lelli SM, Ceballos NR, Mazzetti MB, Aldonatti CA, San Martín de Viale LC. Hexachlorobenzene as hormonal disruptor-studies about glucocorticoids: their hepatic receptors, adrenal synthesis and plasma levels in relation to impaired gluconeogenesis. Biochem Pharmacol 2007;73:873-879.
37. Draper N, Stewart PM. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 2005;186:251-271.
38. Garbrecht MR, Krozowski ZS, Snyder JM, Schmidt TJ. Reduction of glucocorticoid receptor ligand binding by the 11-beta hydroxysteroid dehydrogenase type 2 inhibitor, Thiram. Steroids 2006;71:895-901.
39. Wilding J. Thiazolidinediones, insulin resistance and obesity: Finding a balance. Int J Clin Pract 2006;60:1272-1280.
40. Rebuffé-Scrive M, Krotkiewski M, Elfverson J, Björntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1988;67:1122-1128.